Aura Biosciences Statistics
Total Valuation
AURA has a market cap or net worth of $332.34 million. The enterprise value is $173.14 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AURA has 62.12 million shares outstanding. The number of shares has increased by 14.27% in one year.
| Current Share Class | 62.12M |
| Shares Outstanding | 62.12M |
| Shares Change (YoY) | +14.27% |
| Shares Change (QoQ) | +15.74% |
| Owned by Insiders (%) | 1.52% |
| Owned by Institutions (%) | 43.19% |
| Float | 35.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.39, with a Debt / Equity ratio of 0.10.
| Current Ratio | 12.39 |
| Quick Ratio | 11.94 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.39% and return on invested capital (ROIC) is -33.69%.
| Return on Equity (ROE) | -55.39% |
| Return on Assets (ROA) | -32.14% |
| Return on Invested Capital (ROIC) | -33.69% |
| Return on Capital Employed (ROCE) | -57.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$930,073 |
| Employee Count | 109 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AURA has paid $132,000 in taxes.
| Income Tax | 132,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.36% in the last 52 weeks. The beta is 0.45, so AURA's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -51.36% |
| 50-Day Moving Average | 6.09 |
| 200-Day Moving Average | 6.46 |
| Relative Strength Index (RSI) | 36.63 |
| Average Volume (20 Days) | 308,055 |
Short Selling Information
The latest short interest is 3.14 million, so 5.06% of the outstanding shares have been sold short.
| Short Interest | 3.14M |
| Short Previous Month | 3.14M |
| Short % of Shares Out | 5.06% |
| Short % of Float | 8.91% |
| Short Ratio (days to cover) | 10.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -108.69M |
| Pretax Income | -101.25M |
| Net Income | -101.38M |
| EBITDA | -107.51M |
| EBIT | -108.69M |
| Earnings Per Share (EPS) | -$1.95 |
Full Income Statement Balance Sheet
The company has $177.31 million in cash and $18.11 million in debt, giving a net cash position of $159.20 million or $2.56 per share.
| Cash & Cash Equivalents | 177.31M |
| Total Debt | 18.11M |
| Net Cash | 159.20M |
| Net Cash Per Share | $2.56 |
| Equity (Book Value) | 174.63M |
| Book Value Per Share | 2.81 |
| Working Capital | 169.11M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$83.35 million and capital expenditures -$866,000, giving a free cash flow of -$84.22 million.
| Operating Cash Flow | -83.35M |
| Capital Expenditures | -866,000 |
| Free Cash Flow | -84.22M |
| FCF Per Share | -$1.36 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.27% |
| Shareholder Yield | -14.27% |
| Earnings Yield | -30.50% |
| FCF Yield | -25.34% |
Analyst Forecast
The average price target for AURA is $21.80, which is 307.48% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.80 |
| Price Target Difference | 307.48% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |